US Patent 11166956 Combinations of PDE1 inhibitors and NEP inhibitors
Patent 11166956 was granted and assigned to Intra-Cellular Therapies on November, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11166956 Combinations of PDE1 inhibitors and NEP inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.